Configurational Paths of Depression and Anxiety Symptoms in Ovarian Cancer Patients: A Fuzzy‐Set Qualitative Comparative Analysis
Depression and Anxiety · 2026-01 · 2026 (1)
DOI: 10.1155/da/6451069 ↗At a glance
Vergleichsstudie in Depression and Anxiety, published online on 2026-07-18. Written by Chaoying Ma and 10 co-authors. Institution: Department of Social Medicine, China Medical University, Shenyang, China, cmu.edu.tw. Major MEDLINE topics: Ovarian Neoplasms, Adaptation, Psychological, Anxiety, Depression. 65 references. The full text is freely available (open access, CC BY 4.0). Funded by: China Postdoctoral Science Foundation.
Topics: Onkologische Pflege, Depression
Abstract (original language)
Background
Ovarian cancer is one of the most common gynecological cancers in women. Its diagnosis and treatment often cause significant psychological distress, mainly reflected in depression and anxiety, which arise from multiple interacting factors. This study, grounded in Lazarus’s Stress and Coping Model and from the perspective of set theory, aimed to investigate the correlates and configurational pathways of high and low levels of depression and anxiety symptoms in ovarian cancer patients by integrating stress sources, coping styles, and coping resources.
Methods
The study recruited ovarian cancer patients from a tertiary general hospital in Shenyang, China. The analysis included 169 ovarian cancer patients. The configurational factors included self‐perceived burden (SPB), positive and negative coping styles, self‐esteem, and general self‐efficacy. Multiple linear regression and fuzzy‐set qualitative comparative analysis (fsQCA) were used to explore the factors and configurational pathways related to depression and anxiety symptoms.
Results
The fsQCA identified six configurational pathways linked to high and low levels of depression symptoms. Similarly, the fsQCA identified two configurations linked to high anxiety symptoms and four configurations related to low anxiety symptoms. Moreover, the configurations associated with low psychological symptoms did not stand in opposition to those associated with high psychological symptoms. Substitutability and complementarity were observed among the various elements in the configuration.
Conclusion
The study generated multiple configurational pathways for depression and anxiety symptoms in ovarian cancer patients by examining the combined effects of stress sources, coping styles, and coping resources. The configuration allows caregivers and medical staff to implement targeted measures to reduce burden perception and negative coping, enhance positive coping and self‐esteem considering their substitutability and complementarity.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Social Medicine, China Medical University, Shenyang, China, cmu.edu.tw.
- Department of Gynecology, The First Affiliated Hospital of China Medical University, Shenyang, China, cmu.edu.cn.
ORCID profiles: Chaoying Ma, Li Liu, Yi Zhang, Hui Wu
Funding
- China Postdoctoral Science Foundation
Cite
APA
Ma, C., He, J., Liu, L., Liu, Z., Wang, Y., Guo, H., Xiao, Y., Pan, M., Song, Y., Zhang, Y., & Wu, H. (2026). Configurational Paths of Depression and Anxiety Symptoms in Ovarian Cancer Patients: A Fuzzy‐Set Qualitative Comparative Analysis. Depression and Anxiety, 2026(1). https://doi.org/10.1155/da/6451069
Vancouver
Ma C, He J, Liu L, Liu Z, Wang Y, Guo H, et al. Configurational Paths of Depression and Anxiety Symptoms in Ovarian Cancer Patients: A Fuzzy‐Set Qualitative Comparative Analysis. Depression and Anxiety. 2026;2026(1). doi:10.1155/da/6451069
BibTeX
@article{Ma2026,
author = {Ma, Chaoying and He, Jiani and Liu, Li and Liu, Zhichen and Wang, Yajing and Guo, Hui and Xiao, Yiqun and Pan, Meizhu and Song, Yuli and Zhang, Yi and Wu, Hui},
title = {Configurational Paths of Depression and Anxiety Symptoms in Ovarian Cancer Patients: A Fuzzy‐Set Qualitative Comparative Analysis},
journal = {Depression and Anxiety},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/da/6451069}
}
EUVIMED